Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00209131 · ClinicalTrials.gov registry record · NA

Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy

A NA study, sponsored by Emory University.

Terminated
Registry status
NA
Development phase
24
Enrollment target

NCT00209131: Clinical Trial NA study, sponsored by Emory University.

NCT00209131 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00209131, a NA study, was terminated before completion, sponsored by Emory University.

TERMINATED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The majority of kidney stones are treated with shock wave lithotripsy (SWL). We are examining if the medication Flomax will result in improved stone passage rates following SWL.

Primary Outcome

Time to passage of stone fragments following shock wave lithotripsy as documented by patient diaries and follow-up radiographic imaging.

Interventions

  • DRUG Sugar pill
  • DRUG Flomax

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2005-04
Est. Completion 2009-02
Phase NA
Emory University

1,208 total trials

Why NCT00209131 stopped before completion

NCT00209131 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Sugar pill is the first listed.

NCT00209131 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00209131 about?

NCT00209131 is a clinical study titled "Efficacy of Flomax to Improve Stone Passage Following Shock Wave Lithotripsy". The majority of kidney stones are treated with shock wave lithotripsy (SWL). We are examining if the medication Flomax will result in improved stone passage rates following SWL.

What is the current status of trial NCT00209131?

This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2005-04. Estimated completion is 2009-02.

What interventions are being tested in trial NCT00209131?

The interventions under investigation include: Sugar pill (DRUG), Flomax (DRUG).

Who is sponsoring clinical trial NCT00209131?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00209131's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00209131, the US trial registry maintained by the National Library of Medicine. NCT00209131 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.